{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:53:18Z","timestamp":1790985198464,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bpobgyn.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T06:52:05Z","timestamp":1628146325000},"page":"36-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Adjuvant treatment in cervical, vaginal and vulvar cancer"],"prefix":"10.1016","volume":"78","author":[{"given":"Neerja","family":"Bhatla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8364-0737","authenticated-orcid":false,"given":"Jyoti","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya Nand","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib1","first-page":"120","article-title":"Chemotherapy and targeted therapy in the management of cervical cancer","volume":"42","author":"Kumar","year":"2018","journal-title":"Curr Probl Canc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib2","article-title":"Targeted therapy in cervical cancer","volume":"3","author":"Vora","year":"2019","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2012.04.007","article-title":"Molecularly targeted therapies in cervical cancer. A systematic review","volume":"126","author":"Zagouri","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2009.09.033","article-title":"Anti-angiogenesis agents in metastatic or recurrent cervical cancer","volume":"116","author":"Monk","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.07.005_bib5","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4103\/jcrt.JCRT_39_18","article-title":"Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: a phase II study","volume":"15","author":"Benson","year":"2019","journal-title":"J\u00a0Canc Res Therapeut"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib6","article-title":"PD-1\/PD-L1 immune checkpoint inhibitors in advanced cervical cancer","volume":"5","author":"Saglam","year":"2018","journal-title":"Integr Cancer Sci Ther"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib7","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_sref8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_sref9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ijgo.12969","article-title":"Corrigendum: \"Revised FIGO staging for carcinoma of the cervix uteri","volume":"147","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_sref10","first-page":"129","article-title":"Erratum for","volume":"145","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","article-title":"Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"38","author":"Delgado","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"NCCN guidelines version 5.2019 in cervical cancer","volume":"17","author":"Koh","year":"2019","journal-title":"NCCN (National Comprehensive Cancer Network)"},{"issue":"8","key":"10.1016\/j.bpobgyn.2021.07.005_bib12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0090-8258(89)90598-2","article-title":"Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix","volume":"33","author":"Fuller","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2021.07.005_bib14","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/IGC.0000000000001048","article-title":"Intention-to-treat analysis of radical trachelectomy for early-stage cervical cancer with special reference to oncologic failures","volume":"27","author":"P\u00f3ka","year":"2017","journal-title":"Int J Gynecol Canc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/COC.0000000000000011","article-title":"Evaluation of clinical and pathologic risk factors may reduce the rate of multimodality treatment of early cervical cancer","volume":"39","author":"Gemer","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1438::AID-CNCR10>3.0.CO;2-0","article-title":"Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis","volume":"78","author":"Sevin","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-8140(99)00056-0","article-title":"Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984\u20131996)","volume":"51","author":"Snijders-Keilholz","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0090-8258(90)90374-T","article-title":"Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer","volume":"37","author":"Soisson","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0360-3016(94)00391-W","article-title":"Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure","volume":"31","author":"Stock","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2013.11.019","article-title":"Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins","volume":"132","author":"Diaz","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2004.06.025","article-title":"Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer","volume":"95","author":"Trimbos","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/IGC.0b013e31822fa8bb","article-title":"Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix","volume":"22","author":"Singh","year":"2012","journal-title":"Int J Gynecol Canc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2011.11.048","article-title":"ACR Appropriateness Criteria\u00ae Role of adjuvant therapy in the management of early stage cervical cancer","volume":"125","author":"Wolfson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Practical Radiation Oncology"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"issue":"Suppl 2","key":"10.1016\/j.bpobgyn.2021.07.005_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1 Suppl 1","key":"10.1016\/j.bpobgyn.2021.07.005_bib28","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/j.ygyno.2007.07.026","article-title":"Early stage cervical cancer: adjuvant treatment in negative lymph node cases","volume":"107","author":"Sartori","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2021.07.005_bib29","first-page":"CD007583","article-title":"Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer","volume":"7","author":"Rogers","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0090-8258(89)90627-6","article-title":"Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer","volume":"32","author":"Barter","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ygyno.2012.11.012","article-title":"Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer","volume":"128","author":"Folkert","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.07.005_bib32","first-page":"CD005342","article-title":"Adjuvant platinum-based chemotherapy for early stage cervical cancer","volume":"13","author":"Rosa","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2019.04.039","article-title":"Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: a systematic review and meta-analysis","volume":"238","author":"Li","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib34","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01101451."},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib35","first-page":"1483","article-title":"Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance","volume":"88","author":"Chumworathayi","year":"2005","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib36","first-page":"608","article-title":"Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer","volume":"29","author":"Cetina","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib37","first-page":"1551","article-title":"A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: tohoku Gynecologic Cancer Unit Study","volume":"19","author":"Yokoyama","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2009.08.069","article-title":"Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study","volume":"78","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.07.005_bib39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/ijgc-2019-000690","article-title":"Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy","volume":"30","author":"Zhong","year":"2020","journal-title":"Int J Gynecol Canc"},{"issue":"7","key":"10.1016\/j.bpobgyn.2021.07.005_bib40","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/IGC.0000000000000202","article-title":"Disease committee of uterine cervical and vulvar cancer, Japanese gynecologic oncology group. Surgical principles for managing stage IB2, IIA2, and IIB uterine cervical cancer (bulky tumors) in Japan: a survey of the Japanese gynecologic oncology group","volume":"24","author":"Mikami","year":"2014","journal-title":"Int J Gynecol Canc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1996.0087","article-title":"Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial","volume":"61","author":"Curtin","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib42","article-title":"Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis","volume":"30","author":"Yuan","year":"2020","journal-title":"Int J Gynecol Canc"},{"issue":"7","key":"10.1016\/j.bpobgyn.2021.07.005_bib43","first-page":"4161","article-title":"Adjuvant chemotherapy in locally advanced cervical cancer after treatment with concomitant chemoradiotherapy - room for improvement?","volume":"35","author":"Jelavi\u0107","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0360-3016(02)04405-X","article-title":"Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial","volume":"55","author":"Lorvidhaya","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib45","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2012.01.033","article-title":"Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma","volume":"125","author":"Tang","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2021.07.005_bib47","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.3802\/jgo.2019.30.e82","article-title":"A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial","volume":"30","author":"Tangjitgamol","year":"2019","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"suppl 15","key":"10.1016\/j.bpobgyn.2021.07.005_bib48","first-page":"39","article-title":"A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: outback (ANZGOG0902\/GOG0274\/RTOG1174). (Abstract)","author":"Mileshkin","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2021.07.005_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028171","article-title":"Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijrobp.2020.02.031","article-title":"A phase 1 trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6\/E7 oncogenes after chemoradiation for cervical cancer","volume":"107","author":"Hasan","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib51","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ygyno.2010.12.345","article-title":"The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies","volume":"121","author":"Plante","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.07.005_bib52","first-page":"1537","article-title":"Postoperative radiotherapy following inadvertent simple hysterectomy versus radical hysterectomy for cervical carcinoma","volume":"12","author":"Sharma","year":"2011","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2007.04.004","article-title":"IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy","volume":"106","author":"Lloret","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2021.07.005_bib54","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2008.11.013","article-title":"Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70\/80 and bax downregulation in cervical carcinoma tumors","volume":"73","author":"Lloret","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ygyno.2011.05.037","article-title":"BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy","volume":"122","author":"Henr\u00edquez-Hern\u00e1ndez","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2021.07.005_bib56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12094-013-1018-0","article-title":"Molecular biomarkers in the decision of treatment of cervical carcinoma patients","volume":"15","author":"Valenciano","year":"2013","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib57","first-page":"623","article-title":"Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)","volume":"17","author":"Landoni","year":"2007","journal-title":"Int J Gynecol Canc"},{"issue":"8","key":"10.1016\/j.bpobgyn.2021.07.005_bib58","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ejso.2019.02.017","article-title":"Ovarian function after ovarian transposition and additional pelvic radiotherapy: a systematic review","volume":"45","author":"Hoekman","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.07.005_bib59","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/pon.1426","article-title":"Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study","volume":"18","author":"Greimel","year":"2009","journal-title":"Psycho Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0029-7844(97)00217-2","article-title":"Human papillomavirus infection in postmenopausal women with and without hormone therapy","volume":"90","author":"Ferenczy","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib61","first-page":"304","article-title":"Early-stage vaginal carcinoma\u2014an analysis of 70 patients","volume":"14","author":"Otton","year":"2004","journal-title":"Int J Gynecol Canc"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.07.005_bib62","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/IGC.0000000000000743","article-title":"Role of radical surgery in early stages of vaginal cancer-our experience","volume":"26","author":"Jain","year":"2016","journal-title":"Int J Gynecol Canc"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0090-8258(85)90216-1","article-title":"Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up","volume":"20","author":"Rubin","year":"1985","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1995.1008","article-title":"A\u00a030-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities","volume":"56","author":"Stock","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2021.07.005_bib65","first-page":"1166","article-title":"ACR appropriateness criteria management of vaginal cancer","volume":"27","author":"Lee","year":"2013","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijrobp.2010.08.024","article-title":"Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy","volume":"82","author":"Jhingran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1048-891x.2004.014066.x","article-title":"Chemoradiation for primary invasive squamous carcinoma of the vagina","volume":"14","author":"Dalrymple","year":"2004","journal-title":"Int J Gynecol Canc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.6004\/jnccn.2017.0008","article-title":"Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Koh","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-R","article-title":"Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva","volume":"38","author":"Heaps","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.07.005_bib70","first-page":"733","article-title":"Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes","volume":"68","author":"Homesley","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib71","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","article-title":"Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial","volume":"114","author":"Kunos","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.07.005_bib72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0360-3016(92)90699-I","article-title":"Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"24","author":"Stehman","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib73","doi-asserted-by":"crossref","first-page":"dju426","DOI":"10.1093\/jnci\/dju426","article-title":"Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study","volume":"107","author":"Mahner","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.07.005_bib74","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/0284186X.2019.1687934","article-title":"Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis","volume":"59","author":"Serre","year":"2020","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2020.10.008","article-title":"Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis","volume":"160","author":"van der Velden","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"No.2","key":"10.1016\/j.bpobgyn.2021.07.005_bib76","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0360-3016(97)82500-X","article-title":"Adjuvant radiation for vulvar carcinoma: improved local control","volume":"38","author":"Faul","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib77","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2013.05.036","article-title":"Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma","volume":"130","author":"Viswanathan","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00432-015-2060-9","article-title":"Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins","volume":"142","author":"Ignatov","year":"2016","journal-title":"J\u00a0Canc Res Clin Oncol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2021.07.005_bib79","first-page":"867","article-title":"ACR Appropriateness Criteria Adjuvant therapy in vulvar cancer","volume":"29","author":"Jolly","year":"2015","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.07.005_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2020.09.019","article-title":"Dose-escalated intensity-modulated radiation therapy in patients with locally advanced vulvar cancer - does it increase response rate?","volume":"159","author":"Richman","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.07.005_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.meddos.2018.01.003","article-title":"Integrated skin flash planning technique for intensity-modulated radiation therapy for vulvar cancer prevents marginal misses and improves superficial dose coverage","volume":"44","author":"Dyer","year":"2019","journal-title":"Med Dosim"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2015.03.056","article-title":"Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis","volume":"137","author":"Gill","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2021.07.005_bib83","first-page":"A14","article-title":"Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II","volume":"29","author":"Oonk","year":"2019","journal-title":"Int J Gynecol Canc"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169342100105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169342100105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:12:52Z","timestamp":1761498772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169342100105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":85,"alternative-id":["S152169342100105X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.07.005","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant treatment in cervical, vaginal and vulvar cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}